Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Macquarie Park, NSW-based Aegros operates in Biotechnology Research. Ownership is privately held; it publishes at aegros.com.au. It holds one address on record, all in Australia. The record counts 67 people. Tagged therapeutic plasma products and Building of therapeutic plasma facilities. One Australian registration (ABN) is a confirmed match. It is listed alongside seven similar brands, mostly in Biotechnology Research.
ABN92618589101
| AEGROS LTD | ABN 92618589101 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege.
Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process.
Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma.
Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG)
Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One New South Wales entity on the ABR. AEGROS LTD (ABN 92 618 589 101), high confidence.
The record holds 67 counted staff profiles at January 2026, inside the self-reported 51–200 band.
One address on record, Australia only. Primary: 5 Eden Park Drive, Macquarie Park, NSW 2113.
None linked to this brand.
One tag on the brand's own list, among them Therapeutic plasma products and Building of therapeutic plasma facilities.
28 profiles list Aegros as a peer — 96th percentile in Biotechnology Research. It lists ten peers of its own. Inventia Life Science and Regeneus Ltd list it back.